|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02135 RAILY AESMED
Nominal 
0.148 +0.012 (+8.824%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 199,342 | 189,384 | 164,522 | 188,367 |
| Cost of Sales | -- | -- | (127,935) | (117,891) | (97,739) | (118,675) |
| Gross Profit | -- | -- | 71,407 | 71,493 | 66,783 | 69,692 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (93) | (29) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | (76) | (1,740) | (163) | (152) | |
| Profit / (Loss) before Taxation | -- | -- | (65,257) | (35,010) | (22,101) | (22,948) | |
| Taxation | -- | -- | 1,994 | (2,769) | 1,854 | 4,682 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 4,051 | 5,322 | 4,336 | 575 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,873 | -- | (59,212) | (32,457) | (15,911) | (17,691) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 2,458 | 2,007 | 2,211 | 1,431 |
| Depreciation & Amortisation | -- | -- | 28,158 | 26,182 | 23,193 | 14,528 |
| Directors' Emoluments | -- | -- | 2,528 | 2,862 | 2,412 | 3,096 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 0.340 | -- | -11.110 | -6.750 | -3.312 | -3.695 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.011 | 0.017 | (0.005) | (0.001) |
| NBV per share ($) | -- | -- | 0.187 | 0.287 | 0.346 | 0.370834 |
| Remarks: | Real time quote last updated: 31/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,873 |
| %Change | -- |
| EPS / (LPS) | RMB 0.003 |
| NBV Per Share (¥) | RMB -- |